mRNA Technology Perspective
July 12, 2022 | Terry Sharrer
“[mRNA] vaccines progressed from viral sampling to approval more quickly than any other vaccines in history. They also showed impressive speed in entering large-scale production. By the end of 2021, nearly 3 billion mRNA vaccine doses had been manufactured, even though their production depends on lipid nanoparticle encapsulation, a technology new to mass production.” MORE
Image Credit: Genengnews.com